Gujarat Kidney IPO Day 2: Strong Retail Demand Pushes Subscription Over 2 Times

Market Performance

Gujarat Kidney & Super Speciality IPO, which opened for subscription on Monday, December 22, has continued to attract strong investor interest on its second day. As of 11:51 am on Day 2, the IPO has been subscribed 2.07 times overall, reflecting a significant response from retail investors and non-institutional buyers.

• Retail Individual Investors: 7.73 times subscription
• Non-Institutional Buyers (NIBs): 2.36 times subscription
• Qualified Institutional Buyers (QIBs): 0.34 times subscription

The trend highlights robust demand among smaller investors, while institutional interest remains limited.

Main News: Day 2 Subscription Update

The IPO of Gujarat Kidney and Super Speciality, a mid-sized healthcare provider in central Gujarat, continues to witness active participation from the investor community. The second day of bidding has strengthened the overall subscription figures, indicating healthy market engagement.

Investors have shown a clear preference for the retail category, suggesting confidence in the company’s regional presence and growth potential. Non-institutional investors have also contributed significantly, while institutional uptake remains subdued.

Company Details

Gujarat Kidney and Super Speciality operates a network of seven hospitals across central Gujarat, offering 490 beds in total. The hospital chain focuses on secondary and tertiary care services, providing multi-speciality healthcare solutions to patients in the region.

During the financial year ending March 2025, the company posted:

• Revenue from Operations: ₹40.24 crore
• Net Profit: ₹9.5 crore

This positions the company as a mid-sized, yet well-structured healthcare provider in the central Gujarat market, catering to an underpenetrated regional demand for quality hospital services.

The company’s portfolio also includes four pharmacies within its hospital premises, supporting integrated healthcare delivery for patients and expanding its service footprint.

Summary

Gujarat Kidney IPO Day 2 demonstrates strong interest from retail investors, pushing the overall subscription beyond 2 times. The IPO reflects growing investor engagement in the healthcare sector, particularly in regional hospital chains with established operations and consistent financial performance.

• Retail participation remains the driving force behind the subscription numbers.
• Institutional uptake is modest, signaling selective interest from larger investors.
• The company operates seven hospitals with 490 beds and four in-hospital pharmacies.
• FY25 revenue stands at ₹40.24 crore with a net profit of ₹9.5 crore.

The IPO has captured market attention, reinforcing the demand for healthcare investments in central Gujarat. Investors continue to track subscription updates closely as the bidding progresses into the final days.